Tatsuo Shimura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tatsuo Shimura has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Hideki Suzuki
Department of General Surgical Science (Surgery I), Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
1 shared publicationHiroyuki Kuwano
1 shared publicationKenichiro Araki
Department of General Surgical Science (Surgery I), Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
1 shared publicationKohji Okada
Department of General Surgical Science (Surgery I), Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
1 shared publicationTaketoshi Suehiro
Department of General Surgical Science (Surgery I), Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
1 shared publication
Latest Publications
- 9 May 2007
- Published by Wiley in Journal of Surgical Oncology
- Vol. 96 (5) , 438-441
Trans‐ileocecal portal vein embolization as a preoperative treatment for right trisegmentectomy with caudate lobectomy
Background and Objectives The indication of preoperative portal vein embolization (PVE) has been expanded to hepatocellular carcinoma, cholangiocellular carcinoma (CCC), hepatic metastasis, and gallbladder (GB) cancer as well as hilar cholangiocarcinoma (hCC). However, biliary cancers sometimes cause peritoneal dissemination. Patients and Methods We performed our preoperative trans‐ileocecal‐vein PVE (TIPE) method on 14 (3 GB cancer, 1 CCC, and 10 hCC), whose estimated residual liver volume was P = 0.0002). No major complication due to the procedure was encountered in this series. Conclusions PTPE could be the first choice for patients with hCC, hepatocellular carcinoma, and hepatic metastases. Although the TIPE proposed here has some potential disadvantages, we would recommend it especially for patients with GB cancer because of its high potential to cause cancerous peritonitis. When a patient had predisposing cholangitis, radical operation should be scheduled on >21 days after PVE rather than on 14 days. J. Surg. Oncol. 2007;96:438–441.
- 9 May 2007
- Published by Wiley in Journal of Surgical Oncology
- Vol. 96 (5) , 438-441
Trans‐ileocecal portal vein embolization as a preoperative treatment for right trisegmentectomy with caudate lobectomy
Background and Objectives The indication of preoperative portal vein embolization (PVE) has been expanded to hepatocellular carcinoma, cholangiocellular carcinoma (CCC), hepatic metastasis, and gallbladder (GB) cancer as well as hilar cholangiocarcinoma (hCC). However, biliary cancers sometimes cause peritoneal dissemination. Patients and Methods We performed our preoperative trans‐ileocecal‐vein PVE (TIPE) method on 14 (3 GB cancer, 1 CCC, and 10 hCC), whose estimated residual liver volume was P = 0.0002). No major complication due to the procedure was encountered in this series. Conclusions PTPE could be the first choice for patients with hCC, hepatocellular carcinoma, and hepatic metastases. Although the TIPE proposed here has some potential disadvantages, we would recommend it especially for patients with GB cancer because of its high potential to cause cancerous peritonitis. When a patient had predisposing cholangitis, radical operation should be scheduled on >21 days after PVE rather than on 14 days. J. Surg. Oncol. 2007;96:438–441.